Hepatitis B Supportive Care Protocol
Primary Stack
Core supplements with strongest evidenceDeficiency common in chronic liver disease; supports immune function
Supporting Studies (1)
Antioxidant; may help reduce liver inflammation and fibrosis
Supporting Studies (1)
Supporting Stack
Additional supplements for enhanced resultsHepatoprotective properties; antioxidant; widely used for liver health
Supporting Studies (1)
Deficiency common in liver disease; supports immune function
Supporting Studies (1)
Glutathione precursor; antioxidant support for liver
Supporting Studies (1)
How This Protocol Works
Simple Explanation
Hepatitis B is a viral infection that attacks the liver. It can be acute (short-term) or chronic (lasting more than 6 months).
TRANSMISSION:
ACUTE HEPATITIS B:
CHRONIC HEPATITIS B:
CRITICAL: Hepatitis B requires medical management by a specialist.
MEDICAL TREATMENT:
PREVENTION:
* Avoid alcohol - accelerates liver damage.
* Vaccination prevents new infections.
* Regular monitoring is essential.
Expected timeline: Chronic HBV is a lifelong condition requiring ongoing monitoring. Antiviral treatment can control but rarely cures. Supplements provide supportive care only.
Clinical Perspective
Hepatitis B: DNA virus; 8 genotypes. Acute: most adults clear; infants often become chronic. Chronic HBV: phases (immune tolerant, immune active, inactive carrier, reactivation). Monitoring: HBsAg, HBeAg, HBV DNA, ALT, HCC surveillance.
Treatment: Not all chronic HBV requires treatment - based on HBV DNA, ALT, fibrosis. Antivirals (tenofovir, entecavir) have high efficacy. Functional cure (HBsAg loss) rare. Supplements: limited evidence specific to HBV; general liver support (milk thistle, vitamin E). AVOID hepatotoxic supplements. Discuss ALL supplements with hepatologist.
* Vitamin D (C-grade): Deficiency common. Systematic review: (PMID: 28750270). 2000-4000 IU daily.
* Vitamin E (C-grade): Antioxidant. Review: (PMID: 15322341). 400-800 IU daily.
* Milk Thistle (C-grade): Hepatoprotective. Cochrane: (PMID: 27187333). 200-400mg silymarin TID.
* Zinc (C-grade): Liver disease. Review: (PMID: 22566526). 15-30mg daily.
* NAC (C-grade): Antioxidant. Review: (PMID: 10793665). 600-1200mg daily.
Protocol notes: Vaccination: for all uninfected individuals; post-exposure prophylaxis available. HCC surveillance: ultrasound every 6 months for chronic HBV with cirrhosis or high-risk features. Alcohol: absolute avoidance - synergistic liver damage. Treatment indications: elevated HBV DNA, elevated ALT, significant fibrosis. Drug resistance: rare with current first-line agents. Coinfection: test for HDV (hepatitis D). Immunosuppression: reactivation risk - prophylaxis may be needed. Family screening: test and vaccinate contacts.